We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATVI
1476
DELISTED
Activision Blizzard
ATVI
$469K ﹤0.01%
5,055
-127,710
-96% -$10.4M
CQQQ icon
1477
Invesco China Technology ETF
CQQQ
$2.99B
$468K ﹤0.01%
+5,683
New +$436K
PRGO icon
1478
Perrigo
PRGO
$1.45B
$468K ﹤0.01%
10,460
-184,085
-95% -$8.53M
FIRY
1479
Firy Inc
FIRY
$206M
$467K ﹤0.01%
1,168
-29,458
-96% -$8.75M
SRRK icon
1480
Scholar Rock
SRRK
$5.8B
$467K ﹤0.01%
+9,615
New +$349K
ODT
1481
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$466K ﹤0.01%
24,243
+10,216
+73% +$158K
EFX icon
1482
Equifax
EFX
$21.5B
$465K ﹤0.01%
2,410
-1,051
-30% -$177K
KBH icon
1483
KB Home
KBH
$3.62B
$465K ﹤0.01%
13,861
-133,676
-91% -$4.8M
EMKR
1484
DELISTED
Emcore Corp
EMKR
$463K ﹤0.01%
+8,502
New +$338K
MDB icon
1485
MongoDB
MDB
$24.6B
$462K ﹤0.01%
+1,287
New +$359K
NOVA
1486
DELISTED
Sunnova Energy
NOVA
$462K ﹤0.01%
+10,240
New +$355K
SWBI icon
1487
Smith & Wesson
SWBI
$675M
$459K ﹤0.01%
+25,883
New +$428K
FRC
1488
DELISTED
First Republic Bank
FRC
$457K ﹤0.01%
3,112
-124,389
-98% -$16.2M
TTEK icon
1489
Tetra Tech
TTEK
$8.44B
$455K ﹤0.01%
+19,645
New +$443K
GME icon
1490
GameStop
GME
$9.72B
$454K ﹤0.01%
96,304
+2,412
+3% +$8.3K
GTLS
1491
DELISTED
Chart Industries
GTLS
$451K ﹤0.01%
+3,826
New +$369K
APTO
1492
DELISTED
Aptose Biosciences, Inc.
APTO
$451K ﹤0.01%
+229
New +$538K
SMPL icon
1493
Simply Good Foods
SMPL
$980M
$449K ﹤0.01%
+14,317
New +$333K
FFWM
1494
DELISTED
First Foundation Inc
FFWM
$446K ﹤0.01%
22,294
-72,649
-77% -$1.24M
KRYS icon
1495
Krystal Biotech
KRYS
$10.5B
$446K ﹤0.01%
+7,427
New +$371K
NMFC icon
1496
New Mountain Finance
NMFC
$655M
$445K ﹤0.01%
39,197
+23,595
+151% +$253K
DFS
1497
DELISTED
Discover Financial Services
DFS
$443K ﹤0.01%
4,893
-24,362
-83% -$1.82M
MERC icon
1498
Mercer International
MERC
$46.2M
$443K ﹤0.01%
+43,255
New +$346K
KEP icon
1499
Korea Electric Power
KEP
$14.9B
$442K ﹤0.01%
+36,007
New +$356K
MLI icon
1500
Mueller Industries
MLI
$14.2B
$441K ﹤0.01%
50,276
-228,748
-82% -$1.83M

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.